University of Illinois at Chicago
Exemption #JMG784
Announcement of an Exempt Purchase
Award Info Published Friday August 23, 2019
Awarded to:
Vendor: FFF Enterprises, Temecula, CA
Amount: An estimated $2,700,000
Amount: An estimated $2,700,000
Terms:
An estimated start date of 9/1/2019 through 8/31/2022
Renewals:
None
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Friday, August 23, 2019
The University awarded a contract for Ambrisentan.
Ambrisentan and other restricted medications to treat patients who have Pulmonary Arterial Hypertension.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) This medication will be used to treat patients at UI Health and will ensure better patient outcomes and less re-admissions to the hospital.
For additional information, contact:
Jeffrey Walsh
University of Illinois at Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612-7203
Phone: (312) 355-3568
FAX: (312) 996-3135
University of Illinois at Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612-7203
Phone: (312) 355-3568
FAX: (312) 996-3135
The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.